Est. 2001·3,000+ placements · six offices · four regions
Capital Raisingcurated sourcedetected 2026-11-15 · confidence 80%

Last updated

Neobe: Capital Raising

Cambridge-based Neobe closed a £5.1m seed round to develop engineered bacteria for cancer treatment, with its platform moving toward clinical trials.

Source: Cambridge Independent: Business

Who
Neobe · UK
What happened
Cambridge-based Neobe closed a £5.1m seed round to develop engineered bacteria for cancer treatment, with its platform moving toward clinical trials.
When
2026-11-15
So what
Fresh capital is a hiring signal before it is anything else.

The leadership read

Fresh capital is a hiring signal before it is anything else. For Neobe, a raise in the sector funds leadership depth, scale, go-to-market and operational rigour, rather than any single appointment. Watch where Neobe hires first across EMEA; that is where the capital is really pointed.

Market context: This lands while the Talent Market Index reads 95.4 (Cool) — down 5.3 versus the prior month — and EMEA signal share is rising (+5pts).

Neobe: 1 signal in the last 90 days.

MitchelLake in this thematic

More signals across EMEA

Capital Raising · EMEA

Morgan AI →

Morgan AI, an insolvency-focused fintech/copilot founded by the founders of CoLab, has raised a $3.65M seed round.

Capital Raising · EMEA

Apifa Biotech →

Swedfund International has committed funding to Apifa Biotech to prepare a US$216M pharmaceutical and biotech manufacturing park at Konza Technopolis, Kenya, following April 2026 approval to move to development phase.

Capital Raising · EMEA

Esh →

Israeli digital bank Esh is reportedly preparing a NIS 150 million (about $47 million) capital raise, with co-founder Nir Zuk expected to provide most of the funding after a planned sale to Isracard collapsed in July.

Capital Raising · EMEA

Feldspar →

UK sports tech firm Feldspar is in talks to raise a seed round of roughly £5.5m to £6m from strategic and institutional investors, following three years of family funding.

Capital Raising · EMEA

Watersprint →

Lund-based UVC LED water disinfection company Watersprint is raising EUR 3 million (SEK 35 million) in a new share issue at a valuation of roughly EUR 20 million. It is the company's second capital round this year, following a roughly EUR 2 million raise in March.

Capital Raising · EMEA

VectorY Therapeutics →

Amsterdam-based neurodegenerative biotech VectorY Therapeutics raised EUR 74.5M ($83.5M), with new investors Angelini Ventures, Invest-NL and the European Investment Bank joining returning backers including Forbion, EQT Life Sciences and Eli Lilly.

Where this lands in our work

Weekly briefing

Track companies like Neobe — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record